Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
34,74 USD | -0,29% | -1,14% | +12,87% |
11/04 | Collegium Pharmaceutical gaat $26,35 miljoen aan senior obligaties terugbetalen | MT |
26/02 | COLLEGIUM PHARMACEUTICAL, INC. : Piper Sandler herhaalt koopadvies | ZM |
Omzet 2024 * | 584 mln. 547 mln. | Omzet 2025 * | 596 mln. 558 mln. | Marktkapitalisatie | 1,14 mld. 1,06 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 116 mln. 109 mln. | Nettowinst (verlies) 2025 * | 144 mln. 135 mln. | EV/omzet 2024 * | 2,23 x |
Nettoschuld 2024 * | 167 mln. 157 mln. | Nettoliquiditeiten 2025 * | 42,16 mln. 39,5 mln. | EV/omzet 2025 * | 1,84 x |
K/w-verhouding 2024 * |
11,8
x | K/w-verhouding 2025 * |
9,47
x | Werknemers | 197 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,62% |
Recentste transcriptie over Collegium Pharmaceutical, Inc.
1 dag | -0,29% | ||
1 week | -1,14% | ||
Lopende maand | -10,51% | ||
1 maand | -12,54% | ||
3 maanden | +3,67% | ||
6 maanden | +61,81% | ||
Lopend jaar | +12,87% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 59 | 01-01-02 | |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 31-05-17 |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 24-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 01-01-15 |
Gino Santini
BRD | Director/Board Member | 66 | 24-07-12 |
John Freund
BRD | Director/Board Member | 70 | 01-02-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.25% | 29 M€ | -5,15% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 34,74 | -0,29% | 414 728 |
19-04-24 | 34,84 | +0,20% | 325 386 |
18-04-24 | 34,77 | -1,92% | 203 939 |
17-04-24 | 35,45 | +0,14% | 256 530 |
16-04-24 | 35,4 | +0,74% | 323 773 |
uitgestelde koers Nasdaq, 22 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,87% | 1,14 mld. | |
+25,46% | 659 mld. | |
+26,82% | 557 mld. | |
-4,86% | 359 mld. | |
+16,44% | 322 mld. | |
+8,34% | 297 mld. | |
+6,23% | 215 mld. | |
+7,12% | 210 mld. | |
-6,13% | 200 mld. | |
-8,79% | 149 mld. |